NHS
NICE U-turn on cancer drug despite price increase
June 27, 2014Sales and Marketing Cancer, Glivec, NHS, Novartis, gists
UK pricing watchdog NICE has performed a U-turn on Glivec (imatinib) by issuing new draft guidance recommending the drug, despite …
NICE recommends tenth diabetes drug
June 26, 2014Sales and Marketing Janssen, NHS, diabetes, invokana, type 2
In final guidance NICE has recommended Janssen’s Invokana as a treatment to help lower blood sugar levels in people with …
Review into NHS cover ups
June 25, 2014Sales and Marketing CQC, Francis, Hunt, NHS, UK, robert, whistleblowing
Ministers have ordered a review into the whistleblowing culture within the NHS as it’s announced that 20% of hospitals have …
Data authority chair calls for pharma transparency
June 24, 2014Medical Communications, Sales and Marketing HSCIC, NHS, care data, care.data, manning, transparency
The chair of the UK’s national healthcare information provider says that government and industry have “a lot of work to …
Lilly’s Efient tipped for expanded NICE approval
June 20, 2014Sales and Marketing Effient, Efient, FDA, NHS, blood, lilly, longston, thinner
Eli Lilly’s anti-platelet drug Efient has been given the nod by UK healthcare watchdog NICE for more widespread use, pending …
ABPI president: NICE needs political reform
June 17, 2014Business Services, Medical Communications, Research and Development ABPI, NHS, NICE, Pfizer, QALY, emms, jonathan, vba
NICE needs to be reformed with its QALY formula heavily revised if it is to meet the challenges of 21st …
Knighthoods for Blakemore and Francis
June 17, 2014Medical Communications, Sales and Marketing Francis, Mid Staffs, NHS, blakemore, mdc, queen
Two key figures in healthcare research and reform received knighthoods in the Queen’s Birthday Honours. Professor Colin Blakemore, former head …
NICE rejection looms for Sovaldi
June 16, 2014Sales and Marketing Gilead, NHS, NICE, SMC, hep C, sofosbuvir, sovaldi
In a draft recommendation published today NICE is asking Gilead for more information on its new hepatitis C pill Sovaldi …
NHS staff face prison
June 13, 2014Sales and Marketing Francis, Mid Staffs, NHS, berwick, prison
The government is to create a new statutory criminal offence of ill-treatment or wilful neglect of patients, which could see …
NICE recommends Yervoy
June 13, 2014Sales and Marketing BMS, Cancer, Dillon, NHS, NICE, Yervoy, melanoma
Bristol-Myers Squibb has received a lift from the UK’s drugs watchdog, which has recommended its vaccine Yervoy as a first-line …
Researchers question ‘bias’ NICE on statins
June 11, 2014Sales and Marketing Drug pricing, Haslam, NHS, NICE, statins
Doctors are warning that NICE’s desire to increase prescriptions of statins in England is based on pharma-funded research that ignores …
Andy Burnham: NHS needs a ‘reset’
June 6, 2014Medical Communications, Sales and Marketing Hunt, NHS, burnham, confederation, reset
The NHS must be ‘reset’ in order to make it into a 21st century health service, according to shadow health …
Novo cleared in complaints case
June 5, 2014Medical Communications, Sales and Marketing ABPI, NHS, Novo Nordisk, PMCPA, complaints
Novo Nordisk has been cleared completely of any wrongdoing over a complaint about three of its employees in relation to …
Robert Francis QC joins Care Quality Commission
June 4, 2014Sales and Marketing Hunt, Mid Staffs, NHS, UK, rew, robert francis
Robert Francis QC is to join health watchdog the Care Quality Commission (CQC) as a non-executive director. Francis will be …
Lilly the latest to open up data
June 4, 2014Medical Communications, Research and Development, Sales and Marketing Goldacre, NHS, alltrials, data, lilly, transparency, trials
Eli Lilly is to begin sharing its clinical trial data with scientific researchers through a website housing information from several …
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
